ArticleMolecular therapy oncolytics2017

OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution.

Irene Kuhn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.